CN Stock MarketDetailed Quotes
603079 Zhejiang Shengda Bio-Pharm
- 12.42
- +1.02+8.95%
Market Closed Sep 30 15:00 CST
2.13BMarket Cap-68241P/E (TTM)
12.47High11.40Low101.57KlotVolume11.78Open11.40Pre Close121.66MTurnover5.93%Turnover RatioLossP/E (Static)171.19MShares16.1852wk High1.70P/B2.13BFloat Cap6.9552wk Low12.54Limit Up171.19MShs Float43.21Historical High10.26Limit Down9.39%Amplitude6.95Historical Low0.06Dividend TTM11.98Avg Price50.82KlotAsk0.48%Div YieldTTM100Lot Size47.03KlotBid
Zhejiang Shengda Bio-Pharm Key Stats
EPS
According to the latest financial report of Zhejiang Shengda Bio-Pharm, the latest earnings per share (TTM) for the company is 0.10. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Zhejiang Shengda Bio-Pharm's latest financial report to see how much their book value per share (BVPS) is currently at 7.29.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Zhejiang Shengda Bio-Pharm shows that the company's current ratio is 2.96, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Zhejiang Shengda Bio-Pharm, the quick ratio is 1.90, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Zhejiang Shengda Bio-Pharm? The latest ROE figure is 1.32%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Zhejiang Shengda Bio-Pharm, the total asset return on investment (ROA) is 1.14%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Zhejiang Shengda Bio-Pharm's latest financial report to see how their gross margin is doing - currently at 20.00%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Zhejiang Shengda Bio-Pharm, the net profit margin is 5.07%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data